- /
- Supported exchanges
- / TW
- / 1762.TW
Chunghwa Chemical Synthesis & Biotech Co Ltd (1762 TW) stock market data APIs
Chunghwa Chemical Synthesis & Biotech Co Ltd Financial Data Overview
Chunghwa Chemical Synthesis & Biotech Co., Ltd. engages in the manufacturing, sale, and wholesale of western medicine in Taiwan and internationally. The company offers biotechnology products, including Anidulafungin antifungal medication, Caspofungin Acetate antifungal medication, Dalbavancin Hydrochloride Bacterial Skin Infection Drug, Everolimus, immunosuppressant and anticancer drug), Midostaurin for treating acute myeloid leukemia, Pneumocandin B0 antifungal intermediate, Rapamycin, Rezafungin acetate antifungal medication, Semaglutide weight loss medication, and Tacrolimus immunosuppressant, as well as Mycophenolate Mofetil, Mycophenolate Mofetil HCl, and Mycophenolate Sodium immunosuppressive drugs. It also provides non-biotechnology products, such as Abaloparatide osteoporosis medication, Baricitinib rheumatoid arthritis medication, Brivaracetam antiepileptic drug, Difelikefalin Acetate Pruritus, Edoxaban Tosylate Monohydrate, Eltrombopag Olamine, Eslicarbazepine Actate, Ethyl Icosapentate, Lanreotide Acetateacromegaly), Ozanimod HCl medicine for multiple sclerosis, Ribociclib for breast cancer medication, Plecanatide chronic idiopathic constipation medication, Ribociclib breast cancer medication, Selumetinib Sulfate for neurofibromatosis, Setmelanotide Acetate genetic obesity drug, Sugammadex Sodium anesthesia recovery medication, Tofacitinib Citrate rheumatoid arthritis medication, Trandolapril antihypertensive medication, Trilaciclib Dihydrochloride bone marrow protectant, Tenapanor HCl medication for constipation-predominant irritable bowel syndrome and hyperphosphatemia in dialysis patients. The company was formerly known as China Chemical Synthesis Industry Co., Ltd. and changed its name to Chunghwa Chemical Synthesis & Biotech Co., Ltd. in January 2003. Chunghwa Chemical Synthesis & Biotech Co., Ltd. was founded in 1964 and is headquartered in New Taipei City, Taiwan.
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Chunghwa Chemical Synthesis & Biotech Co Ltd (top by weight)
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get Chunghwa Chemical Synthesis & Biotech Co Ltd data using free add-ons & libraries
Get Chunghwa Chemical Synthesis & Biotech Co Ltd Fundamental Data
Chunghwa Chemical Synthesis & Biotech Co Ltd Fundamental data includes:
- Net Revenue: 934 M
- EBITDA: 49 986 K
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
Get Chunghwa Chemical Synthesis & Biotech Co Ltd Earnings data
Corporate Events Calendar & News package for
What’s included:
- Latest Release: 2026-03-31
- EPS/Forecast: -0.2
Get Chunghwa Chemical Synthesis & Biotech Co Ltd End-of-day data
EOD Historical Data package for
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.